Koustubh Ranade

Koustubh joined Immunocore in 2019 as Head of Translational Medicine. He was most recently Vice President of Translational Medicine at MedImmune for all therapeutic areas, where he contributed to four product approvals, including durvalumab. With over three decades of research experience at Genentech, BMS, Stanford and NIH, Koustubh is a co-inventor on many patents, has published extensively in top-tier journals and has edited a book on the application of genomics to drug development. Koustubh received his PhD in molecular genetics from the University of Massachusetts Medical School.